Fitt Insider cover image

Create Scores $20M, Eli Lilly Bets on AI Drugs, Landmark Social Media Verdict

Fitt Insider

00:00

Pharma Uses GLP-1 Profits to Fund AI R&D

Joe Vinayor describes Lilly's strategy: reinvesting GLP-1 revenue into AI, NVIDIA co-innovation, and next-gen pipelines.

Play episode from 01:05
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app